Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.490
-0.070 (-1.54%)
Apr 23, 2026, 11:25 AM EDT - Market open
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$72,875
Profits / Employee
-$1,675,063
Market Cap
233.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| MediWound | 121 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| OmniAb | 89 |
| Keros Therapeutics | 78 |
| ALX Oncology Holdings | 43 |
| Fennec Pharmaceuticals | 35 |
CAMP News
- 5 days ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - CAMP4 Appoints Michael MacLean to its Board of Directors - GlobeNewsWire
- 6 weeks ago - CAMP4 to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 4 months ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire